Net Sales at Rs 492.30 crore in June 2019 down 8.6% from Rs. 538.60 crore in June 2018.
Quarterly Net Profit at Rs. 143.20 crore in June 2019 down 21.15% from Rs. 181.60 crore in June 2018.
EBITDA stands at Rs. 212.30 crore in June 2019 down 16.25% from Rs. 253.50 crore in June 2018.
Natco Pharma EPS has decreased to Rs. 7.87 in June 2019 from Rs. 9.84 in June 2018.
Natco Pharma shares closed at 552.95 on August 08, 2019 (NSE) and has given -18.92% returns over the last 6 months and -31.99% over the last 12 months.
Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights & analysis For more information, check out the Moneycontrol website or mobile app.